BUSE Q1 2026 Earnings Strong EPS Beat Drives Optimism Fate Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Pipeline Development PNC Q1 2026 Earnings Modest EPS Beat Reflects Resilient Core Operations INDV Q1 2026 Earnings EPS Beat Drives 437 Surprise as Stock Declines Burford Capital Q1 2026 Earnings Massive EPS Miss as Litigation Outcomes Weigh TECX Q1 2026 Earnings EPS Miss as PreCommercial Biotech Advances Pipeline